Ashish M. Kamat: Deintensification of Treatment for Low-grade Bladder Tumors

Ashish M. Kamat posted on X about recent paper by Roberto Contieri et al., titled “Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)” published on Science Direct.

Authors: Roberto Contieri, Mark S. Soloway, Paolo Gontero, Harry Herr, Wassim Kassouf, Laura S. Mertens, Marco Moschini, Michael O’Donnell, Joan Palou, Sarah P. Psutka, Morgan Rouprêt, Jeremy Y.C. Teoh, Ashish M. Kamat.

“Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)”

Source: Ashish M. Kamat/X

Ashish M. Kamat is the Endowed Professor of Urologic Oncology (Surgery) and Cancer Research at University of Texas MD Anderson Cancer Center. He is also President of the International Bladder Cancer Group (IBCG) and International Bladder Cancer Network (IBCN).

He is Associate Editor for European Urology Oncology, Editor for the UroToday Bladder Cancer Center of Excellence, directed the MDACC Urologic Oncology Fellowship from 2005-2016, and is an alumnus of the AUA Leadership Program.